Endogena Therapeutics Completes Dose Escalation in the Phase 1/2a Clinical Trial of EA-2353 for the Treatment of Retinitis Pigmentosa
SAN FRANCISCO and TORONTO and ZÜRICH, Switzerland, April 05, 2023 (GLOBE NEWSWIRE) — Endogena Therapeutics…
SAN FRANCISCO and TORONTO and ZÜRICH, Switzerland, April 05, 2023 (GLOBE NEWSWIRE) — Endogena Therapeutics…
ANN ARBOR, Mich., April 05, 2023 (GLOBE NEWSWIRE) — Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB)…
ANN ARBOR, Mich., April 05, 2023 (GLOBE NEWSWIRE) — Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB)…
ALPHARETTA, Ga., April 05, 2023 (GLOBE NEWSWIRE) — Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical company revolutionizing…
ALPHARETTA, Ga., April 05, 2023 (GLOBE NEWSWIRE) — Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical company revolutionizing…
CDMO Services Focused on Longboard’s Oral, Centrally Acting 5-HT2C Receptor Superagonist, Being Developed for the…
CDMO Services Focused on Longboard’s Oral, Centrally Acting 5-HT2C Receptor Superagonist, Being Developed for the…
SparingVision appoints Joseph C. Papa as Chairman Former Bausch and Lomb Chairman and CEO joins…
SparingVision appoints Joseph C. Papa as Chairman Former Bausch and Lomb Chairman and CEO joins…
Data from Animal Studies on TNX-1700 (recombinant TFF2 – albumin fusion peptide) in Syngeneic Models…
Data from Animal Studies on TNX-1700 (recombinant TFF2 – albumin fusion peptide) in Syngeneic Models…
VIENNA, Austria, April 05, 2023 (GLOBE NEWSWIRE) — Proxygen, a leader in the discovery and…
VIENNA, Austria, April 05, 2023 (GLOBE NEWSWIRE) — Proxygen, a leader in the discovery and…
AC Immune to Host Key Opinion Leader Webinar on Early Diagnosis and Prevention of Alzheimer’s…
AC Immune to Host Key Opinion Leader Webinar on Early Diagnosis and Prevention of Alzheimer’s…
ZUG, Switzerland and BOSTON, April 05, 2023 (GLOBE NEWSWIRE) — Oculis Holding AG (Nasdaq: OCS)…
ZUG, Switzerland and BOSTON, April 05, 2023 (GLOBE NEWSWIRE) — Oculis Holding AG (Nasdaq: OCS)…
International Biopharma Executive Brings Nearly Twenty Years of Financial and Strategic Experience CAMBRIDGE, Mass., April…
International Biopharma Executive Brings Nearly Twenty Years of Financial and Strategic Experience CAMBRIDGE, Mass., April…
BOSTON, April 05, 2023 (GLOBE NEWSWIRE) — TransCode Therapeutics, Inc. (NASDAQ: RNAZ), the RNA Oncology…